ContractClinical Study Agreement • November 17th, 2020
Contract Type FiledNovember 17th, 2020CLINICAL STUDY AGREEMENT No.08/OVZ/16/047-P SMLOUVA O KLINICKÉM HODNOCENÍ č.08/OVZ/16/047-P This Clinical Study Agreement (this “Agreement”), is effective upon signature of the last party (the “Effective Date”), is between Edge Therapeutics, Inc., a Delaware corporation (“Sponsor”) represented in the European Union by PBS Regulatory Consulting Group Pvt Ltd., having its principal office at 5 E Vows Walk, Kirkcaldy KY1 1SQ, UK and Fakultní nemocnice Ostrava,17. Listopadu 1790/5, 708 52 Ostrava – Poruba, Czech Republic, IČ: 00843989, DIČ: CZ00843989, Deed of foundation Ministry of health dated 25 November 1990 ref. OP054-25.11.90, in matters of this agreement is entitled to act and sign: MUDr. Josef Srovnal, deputy director for medical care, Bank: Česká národní banka, Na Příkopě 28, 115 03 Praha 1, Czech Republic, Account number: 66332761/0710, IBAN: CZ59 0710 0000 0000 6633 2761, BIC code (SWIFT): CNBACZPP, Variable symbol: 649071037 (the “Site”), and MUDr. Tomáš Hrbáč, Ph.D., MBA, an